InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-08 · accession 0001415889-22-012320 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-09 2022-12-08 UTHR BENKOWITZ MICHAEL Pres AND COO D - Sale to Iss $279.88 -8,000 2,353 -77% -$2.24M
D 2022-12-09 2022-12-08 UTHR BENKOWITZ MICHAEL Pres AND COO M - OptEx $94.96 +8,000 10.4K +340% +$759.7K
D 2022-12-09 2022-12-08 UTHR BENKOWITZ MICHAEL Pres AND COO M - OptEx $0.00 -8,000 32.0K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-08 D D 8,000 $279.88 2,353 D — —
2 Common Common Stock 2022-12-08 M A 8,000 $94.96 10,353 D — —
3 Derivative Share Tracking Award 2022-12-08 M D 8,000 $0.00 32,000 D $94.96 · 2015-03-14 to 2024-03-14 8,000 Common Stock (F2) Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.